Sector News

DuPont lifts first-quarter outlook, shores up balance sheet as COVID-19 clouds view

April 21, 2020
Chemical Value Chain

DuPont lifted its first-quarter earnings outlook as the coronavirus disease 2019 (COVID-19) pandemic bolsters demand for products such as Tyvek protective fabric, but withdrew its full-year guidance and announced steps to improve its balance sheet because the virus’s longer-term impacts on markets such as automotive and oil and gas remains unclear.

DuPont expects first-quarter 2020 adjusted earnings of $0.82–0.84/share, well above the analysts’ consensus estimate of $0.68/share, as reported by Refinitiv (New York), and the company’s initial first-quarter guidance of $0.70–0.74/share, issued on 11 March.

First-quarter net earnings are expected to be $.70–$1.00/share, on net sales of approximately $5.2 billion. The company expects a first-quarter loss from continuing operations in the range of $510–725 million operating EBITDA of approximately $1.3 billion.

The company acknowledged significant uncertainty for the rest of the year and weakness in automotive, oil and gas, and industrial markets due to COVID-19, and withdrew its full-year guidance. “[A]s this pandemic expands globally, the uncertainty around demand in select end-markets continues,” said Ed Breen, Executive Chairman and CEO. “In response, we continue to advance initiatives to improve our working capital and have taken steps to delay certain capital investments and idle production at several manufacturing sites.”

The company entered into a 364-day, $1.0-billion revolving credit facility, replacing the $750 million revolving credit facility that was set to expire in June 2020, and secured a $2.0-billion, 364-day delayed-draw facility ensuring its ability to meet the November 2020 maturities. “Securing these two new facilities further strengthens our near-term liquidity position,” Breen says. “Additionally, we now have committed financing in place to bridge our debt maturing in November 2020 to the receipt of the special cash payment in connection with the Nutrition & Biosciences and IFF transaction. Combined with our existing cash balances and available borrowings through our commercial paper program, these facilities provide the liquidity needed to navigate these uncertain times.”

DuPont has also idled production at several manufacturing sites, predominantly production plants within the transportation and industrial segment, due to significant downturn in automotive production.

The company will report first-quarter results on 5 May.

By: Rebecca Coons

Source: Chemical Week

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 23, 2021

Supervisory Board of Bayer AG appoints Sarena Lin to Board of Management as Chief Transformation and Talent Officer

Chemical Value Chain

Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.

January 23, 2021

Johnson Matthey’s battery plant in Poland to be powered by renewable electricity 

Chemical Value Chain

Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.

January 23, 2021

Oxford given £100m for antibiotic resistance research

Chemical Value Chain

Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.

Send this to a friend